Rikoon Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.6M Sell
13,516
-410
-3% -$48.1K 0.43% 49
2020
Q4
$1.64M Sell
13,926
-121
-0.9% -$13.3K 0.46% 45
2020
Q3
$1.47M Buy
14,047
+2,426
+21% +$244K 0.45% 48
2020
Q2
$1.07M Buy
11,621
+5,015
+76% +$481K 0.36% 69
2020
Q1
$598K Buy
6,606
+4,146
+169% +$441K 0.25% 96
2019
Q4
$279K Buy
2,460
+365
+17% +$40.1K 0.1% 178
2019
Q3
$229K Sell
2,095
-165
-7% -$17.2K 0.08% 184
2019
Q2
$220K Buy
2,260
+65
+3% +$5.93K 0.08% 191
2019
Q1
$201K Hold
2,195
0.07% 200
2018
Q4
$200K Buy
2,195
+35
+2% +$3.27K 0.08% 191
2018
Q3
$212K Buy
+2,160
New +$200K 0.08% 202
2017
Q3
Sell
-2,423
Closed -$215K 165
2017
Q2
$215K Sell
2,423
-825
-25% -$69.6K 0.1% 159
2017
Q1
$270K Sell
3,248
-1,521
-32% -$119K 0.12% 143
2016
Q4
$363K Sell
4,769
-1,706
-26% -$134K 0.16% 122
2016
Q3
$559K Buy
+6,475
New +$564K 0.44% 67

Other funds holding MDT

Rikoon Group's MDT Position: Q1 2021 in Review

Rikoon Group reduced its Medtronic (MDT) stake by 2.9% in Q1 2021, selling an estimated $48.1K and leaving 13,516 shares worth $1.6M. The position accounts for 0.43% of the portfolio, ranked #49.

Rikoon Group first reported a position in MDT in Q3 2016 and has held it in 15 quarters since. The position peaked at $1.64M in Q4 2020. 1,977 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • Rikoon Group held 13,516 shares of Medtronic worth $1.6M as of Q1 2021.
  • Rikoon Group sold 410 Medtronic shares in Q1 2021, an estimated $48.1K.
  • Medtronic made up 0.43% of Rikoon Group's portfolio in Q1 2021, its #49 holding.
  • Rikoon Group first reported a position in Medtronic in Q3 2016 and has held it in 15 quarters since.
  • Rikoon Group's Medtronic position peaked at $1.64M in Q4 2020.
  • 1,977 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.